Aveo Pharmaceuticals Inc (AVEO.OQ)
AVEO.OQ on NASDAQ Stock Exchange Capital Market
2.49USD
19 Oct 2018
2.49USD
19 Oct 2018
Change (% chg)
$-0.04 (-1.58%)
$-0.04 (-1.58%)
Prev Close
$2.53
$2.53
Open
$2.53
$2.53
Day's High
$2.60
$2.60
Day's Low
$2.47
$2.47
Volume
547,731
547,731
Avg. Vol
515,104
515,104
52-wk High
$3.58
$3.58
52-wk Low
$1.86
$1.86
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
| Name | Age | Since | Current Position |
|---|---|---|---|
Michael Bailey |
49 | 2015 | President, Chief Executive Officer, Director |
Matthew Dallas |
41 | 2017 | Chief Financial Officer |
Karuna Rubin |
2018 | Senior Vice President, General Counsel | |
Nikhil Mehta |
2017 | Senior Vice President - Regulatory and Quality Assurance | |
Mike Ferraresso |
2018 | Vice President - Business Analytics and Commercial Operations |